Table 2 |
||
|
Preferences for asthma preventive medication use in pregnancy (n = 174) |
||
|
Asthma preventive medication class |
n (%) |
|
|
|
||
|
First preference |
Second preference |
|
|
|
||
|
Cromones |
13 (7.5%) |
22 (12.6%) |
|
Leukotriene receptor antagonists (LTRA) |
5 (2.9%) |
3 (1.7%) |
|
Inhaled corticosteroids (ICS) |
129 (74.1%) |
24 (13.8%) |
|
Long-acting beta2 agonists (LABA) |
10 (5.7%) |
11 (6.3%) |
|
LABA/ICS combination |
36 (20.7%) |
73 (42.0%) |
|
|
||
|
*Some numbers do not add up to 174 due to missing data |
||
|
Lim et al. BMC Family Practice 2011 12:121 doi:10.1186/1471-2296-12-121 |
||
